Region Uppsala — Sponsor Intelligence | 13 EU Trials

Filter these 13 trials by condition, phase, country and more.

Open in Search →

13 Registered trials

6 Recruiting

5 Completed trials

4 Countries active

22 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 7 Phase IV: 3 Phase I: 1

Oversight events:

1 serious breach across 1 trial

View oversight register →

100%

5 of 5 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Chronic myeloid leukaemia 1 Normal pressure hydrocephalus 1 Multiple sclerosis 1 Hormonal contraception 1

Top IMPs

CYCLOSERINE 1 DASATINIB 1 METFORMIN HYDROCHLORIDE 1 PROTRANS 1

All trials

13 total

HiHat trial Pending

2024-519700-28-01 Phase II 1 country
Magnetic Resonance Assessment of Variations in Effects of anaesthesia on renaL perfusion in children Pending

2025-520627-25-00 Phase IV 1 country
AIDA-DEP - Accelerated Intermittent theta-burst stimulation with D-cycloserine Augmentation for DEPression - a multicenter, randomized, plac… Recruiting

2025-521686-27-01 Phase II 1 country CYCLOSERINE
WJMSC-P01 Recruiting

2024-518270-14-00 Phase II 1 country PROTRANS
RA-P-OCD-01 Recruiting

2024-518391-31-00 Phase II 1 country
Influence of antibiotic treatment on the normal flora and the presence of resistance genes in known carriers of ESBL and VRE Recruiting

2024-517434-17-01 Phase IV 1 country
Improved Recovery by Iron following Surgery with blood loss, a double-blind multi-centre randomized controlled phase III drug trial (the IRI… Recruiting

2022-502776-22-00 Phase III 1 country
A multicenter trial where patients with CML stop medication a second time. Recruiting

2024-515409-25-00 Phase II 3 countries DASATINIB
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction SPIRRIT-HFpEF Ended

2024-517448-79-00 Phase III 1 country
Treatment of normal pressure hydrocephalus with acetazolamide Ended

2024-514828-16-00 Phase II 1 country
Brain effects of hormonal contraceptives. Ended

2023-507842-10-00 Phase IV 1 country
Metformin Intervention in children and adolescents with obesity. A parallel, three arms, randomized, 6 months, multi-center study with metfo… Ended

2024-517787-29-00 Phase II 1 country METFORMIN HYDROCHLORIDE
MESENCHYMAL STROMAL CELL THERAPY FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME - Validation of Mechanistic Pathways and Clinical … Ended

2024-518160-13-00 Phase I 1 country

Showing 1–13 of 13 trials

← All sponsors A–Z